SS-31 (Elamipretide)
Category: Mitochondrial Peptide
A mitochondria-targeted peptide being studied for cardiomyopathy and mitochondrial disorders.
Half-Life: 1 hours
Benefits
- May improve mitochondrial function
- Potential cardiac protective effects
- Explored in ophthalmic formulations
Side Effects
- Injection site reactions
- Headache
- Nausea